ALLR Deadline: ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit
Portfolio Pulse from
Rosen Law Firm is inviting investors who purchased Allarity Therapeutics, Inc. (NASDAQ: ALLR) securities between May 17, 2022, and July 19, 2024, to lead a securities fraud lawsuit. The deadline for lead plaintiff applications is November 12, 2024.
November 08, 2024 | 2:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Rosen Law Firm is seeking lead plaintiffs for a securities fraud lawsuit against Allarity Therapeutics, Inc. Investors who purchased shares between May 17, 2022, and July 19, 2024, may be eligible for compensation.
The announcement of a securities fraud lawsuit can negatively impact investor sentiment and lead to a decline in stock price. The potential for legal liabilities and reputational damage is significant, hence a negative short-term impact is expected.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100